Sign in
CDMO Stock Price, Chart, Stats & News
Avid Bioservices, Inc.
Save
798.90M
Market cap
–
Current P/E
–
Forward P/E
CDMO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 5.23% |
Operating margin | -13.35% |
Pretax margin | -19.25% |
Net margin | -100.60% |
Effective tax rate | -422.72% |
ROA | -41.82% |
ROE | -112.44% |
D/E | 3.41x |
Interest coverage ratio | -4.31x |
CDMO valuation
P/E | – |
P/S | 5.71x |
P/B | 12.96x |
P/CF | 72.07x |
P/FCF | -38.31x |
P/OCF | 72.07x |
PEG | 1.06x |
EV multiple | -54.80x |
About
Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. Their core expertise lies in compounds derived from mammalian cell culture, providing both clinical and commercial scale manufacturing solutions. The company is proficient in producing critical therapeutics such as monoclonal antibodies and recombinant proteins.
Similar securities
Based on sector and market capitalization
Report issue